Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.

Background: Doppler ultrasound arterial abnormalities (DAA) after orthotopic liver transplantation (OLT) often represent a sign of hepatic artery (HA) complication (HAC). The standard management of DAA involves computed tomographic angiography (CTA) followed by invasive vascular intervention (IVI) or observation. We evaluated the contribution of systemic vasodilators (SVD) to the management of DAA after OLT. Methods: Between 2005 and 2015, 91 out of 514 OLT recipients developed DAA (defined by HA resistive index [HARI] 0.5), improvement-group (HARI increase of >0.1 but value 30 days were associated with clinically significant HAC. Specificity and accuracy of DUS after SVD increased from 88.1% to 95.1% and from 88.9% to 95.1% (p

from #ENT via xlomafota13 on Inoreader http://ift.tt/2bLnYvp
via IFTTT